Skip to main content
OLIPASS CORPORATION logo

OLIPASS CORPORATION — Investor Relations & Filings

Ticker · 244460 ISIN · KR7244460002 KO Professional, scientific and technical activities
Open in API
Filings indexed 507 across all filing types
Latest filing 2024-01-05 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 244460

About OLIPASS CORPORATION

https://www.olipass.com/front/eng/index…

OLIPASS CORPORATION is a research and development company focused on creating RNA therapeutics. The company's core activities are centered on its proprietary OliPass Peptide Nucleic Acid (OPNA) platform. OPNA is a novel technology derived from Peptide Nucleic Acid (PNA) by introducing a cationic lipid moiety onto the nucleobase. This structural modification is designed to markedly improve cell permeability, a key challenge in nucleic acid-based drug delivery. The platform is optimized to induce exon skipping by specifically binding to target pre-mRNA inside the cell nucleus, enabling the discovery and development of new therapeutic candidates.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) and specifically acts as a 'Correction Report' (정정신고) for a previously filed document. It details changes to the issuance terms, such as the purpose of funds, maturity dates, interest payment schedules, and conversion prices. This type of filing is a standard regulatory disclosure for corporate financing activities in the Korean market, which falls under the 'Capital/Financing Update' category.
2024-01-05 Korean
주주명부폐쇄기간또는기준일설정(임시주주총회)
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice regarding the setting of a record date and share register closure period for an upcoming Extraordinary General Meeting (EGM). It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal regulatory announcement of the meeting logistics. Given the nature of the announcement regarding shareholder rights and meeting preparation, it falls under the general regulatory filing category.
2024-01-05 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주요사항보고서(유상증자결정) 정정신고' (Report on Material Matters: Amendment to Capital Increase Decision). It details changes to a previously announced capital increase (private placement), including adjustments to the number of shares, issuance price, and payment dates. This falls under the category of share issuance and capital structure changes.
2023-12-26 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korean financial authorities (FSC/KRX) regarding the 'Correction of Issuance of Convertible Bonds' (전환사채권 발행결정 정정신고). It details specific changes to the terms of a previously announced convertible bond issuance, such as maturity dates, interest payment schedules, and put option dates. This falls under the category of capital structure and financing updates.
2023-12-26 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange, specifically detailing the decision to issue convertible bonds (전환사채권 발행결정). This type of filing is a regulatory requirement for public companies in Korea to disclose significant corporate events, such as capital raising through debt instruments. It fits the 'Capital/Financing Update' (CAP) category as it details the terms, interest rates, conversion rights, and use of proceeds for a new financing transaction.
2023-12-19 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from Olipass Co., Ltd. regarding the issuance of convertible bonds (전환사채권 발행결정). This is a formal regulatory filing in South Korea used to disclose significant corporate events, specifically financing activities involving debt-to-equity instruments. Since it details the terms, purpose, and issuance of convertible bonds, it falls under the 'Capital/Financing Update' category.
2023-12-19 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.